ロード中...
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma
BACKGROUND: Fluticasone furoate is a once-daily inhaled corticosteroid. This report provides an overview of safety and efficacy data that support the use of once-daily fluticasone furoate 100 μg or 200 μg in adult and adolescent asthma patients. METHODS: Fourteen clinical studies (six Phase II and e...
保存先:
| 出版年: | Respir Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122018/ https://ncbi.nlm.nih.gov/pubmed/27881132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0473-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|